• Mashup Score: 2

    Virtual Dialogue 4 Registration Chondrosarcoma Foundation, Inc. Moving Forward in Diagnosing & Treating Chondrosarcoma Fourth International Virtual Dialogue (VIA Zoom) Date: Saturday, April 30, 2022 Time: 1:00PM – 2:30PM (EST / New York) Click here to Register The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent…

    Tweet Tweets with this article
    • .@CS_Foundation1 will host their 4th International Forum / Virtual Dialogue: Moving Forward in Diagnosing and Treating #Chondrosarcoma on 4/30 at 1:00pm via Zoom. Register here: https://t.co/isxDxhkMCs #Cswecare

  • Mashup Score: 0

    Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterized by the production of cartilaginous matrix and are generally resistant to radiation and chemotherapy and the outcomes are overall poor. Hence, there is strong interest in determining mechanisms of cancer aggressiveness and therapeutic resistance in chondrosarcomas. There are metabolic alterations…

    Tweet Tweets with this article
    • A new review from Jefferson's @idamicaily & @basumallickmd focuses on metabolic changes in #chondrosarcoma, as well as potential treatment strategies targeting metabolism, including potential synergy with immunotherapies: https://t.co/Wgod6Ku4Eh @FrontOncology #BoneCancer